A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

NCT03060850 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Lymphoma

Interventions

DRUG: AC0010MA

Sponsor

Hangzhou ACEA Pharmaceutical Research Co., Ltd.